PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2012 | 10 | 2 | 338-353
Article title

Thermodynamic dissociation constants of risedronate using spectrophotometric and potentiometric pH-titration

Content
Title variants
Languages of publication
EN
Abstracts
EN
Risedronate inhibits bone resorption in diseases like osteoporosis, Paget’s disease, tumor bone diseases or the malfunction of phosphocalcium metabolism. The acid-base properties of risedronate in an aqueous solution have been studied in a pH range from 2 to 12 and can be described in terms of four dissociation steps: pK a,2, pK a,4, pK a,5 (related to the dissociation of POH groups) and pK a,3 related to the dissociation of protonated amino group NH3+. The mixed dissociation constants were determined at different ionic strengths I = 0.02 to 0.20 mol dm−3 KCl and of 25°C and 37°C using pH-spectrophotometric and pH-potentiometric titration methods. Determination of group parameters L 0, H T might lead to false estimates of common parameters p K a;therefore, the computational strategy employed is important. A comparison between the two programs ESAB and HYPERQUAD demonstrated that the ESAB program provides a better fit of potentiometric titration curve. The thermodynamic dissociation constants pK aT were estimated by a nonlinear regression of (pK a, I) data and a Debye-Hückel equation at 25°C and 37°C, pK a,2T = 2.37(1) and 2.44(1), pK a,3T = 6.29(3) and 6.26(1), pK a,4T = 7.48(1) and 7.46(2) and pK a,5T = 9.31(7) and 8.70(3) at 25°C and 37°C using pH-spectroscopic data and pK a,2T = 2.48(3) and 2.43(1), pK a,3T= 6.12(2) and 6.10(2), pK a,4T = 7.25(2) and 7.23(1) and pK a,5T = 12.04(5) and 11.81(2) at 25°C and 37°C. The ascertained estimates of three dissociation constants pK a,3, pK a,4, pK a,5 are in agreement with the predicted values obtained using PALLAS [...]
Publisher

Journal
Year
Volume
10
Issue
2
Pages
338-353
Physical description
Dates
published
1 - 4 - 2012
online
29 - 1 - 2012
Contributors
author
  • Department of Analytical Chemistry, University of Pardubice, CZ 532 10, Pardubice, Czech Republic, milan.meloun@upce.cz
  • Department of Analytical Chemistry, University of Pardubice, CZ 532 10, Pardubice, Czech Republic
  • Department of Analytical Chemistry, University of Pardubice, CZ 532 10, Pardubice, Czech Republic
  • Zentiva k.s., CZ 102 37, Prague, Czech Republic
References
  • [1] H. Fleisch, R.G.G. Russell, S. Bisaz, P.A. Casey, Muhlbaue.Rc. Calc. Tiss Res. S 2, 10 (1968) http://dx.doi.org/10.1007/BF02065192[Crossref]
  • [2] H. Fleisch, R.G.G. Russell, M.D. Francis, Science 165, 1262 (1969) http://dx.doi.org/10.1126/science.165.3899.1262[Crossref]
  • [3] M.D. Francis, R.G.G. Russell, H. Fleisch, Science 165, 1264 (1969) http://dx.doi.org/10.1126/science.165.3899.1264[Crossref]
  • [4] P. Miller, C. Roux, M. McClung, S. Adami, R. Eastell, S. Pack, D. Ethgen, Arthritis Rheum. 42, S287 (1999)
  • [5] L. Mortensen, P. Charles, P.J. Bekker, J. Digennaro, C.C. Johnston, J. Clin. Endocr. Metab. 83, 396 (1998) http://dx.doi.org/10.1210/jc.83.2.396[Crossref]
  • [6] M.R. McClung, W. Bensen, M.A. Bolognese, S.L. Bonnick, M.P. Ettinger, S.T. Harris, H. Heath, R. Lang, P.D. Miller, E.P. Pavlov, S.L. Silverman, G.C. Woodson, K.J. Faulkner, P.J. Bekker, D.W. Axelrod, J. Bone Miner Res. 12, P269 (1997)
  • [7] H.L. Guenther, H.E. Guenther, H. Fleisch, Biochem. J. 196, 293 (1981)
  • [8] M. Tsuchimoto, Y. Azuma, O. Higuchi, I. Sugimoto, N. Hirata, M. Kiyoki, I. Yamamoto, Jpn. J. Pharmacol. 66, 25 (1994) http://dx.doi.org/10.1254/jjp.66.25[Crossref]
  • [9] N. Giuliani, M. Pedrazzoni, G. Negri, G. Passeri, M. Impicciatore, G. Girasole, Bone 22, 455 (1998) http://dx.doi.org/10.1016/S8756-3282(98)00033-7[Crossref]
  • [10] R.G.G. Russell, M.J. Rogers, Bone 25, 97 (1999) http://dx.doi.org/10.1016/S8756-3282(99)00116-7[Crossref]
  • [11] H. Fleisch, Endocr. Rev. 19, 80 (1998) http://dx.doi.org/10.1210/er.19.1.80[Crossref]
  • [12] J.M. Rondeau, F. Bitsch, E. Bourgier, M. Geiser, R. Hemmig, M. Kroemer, S. Lehmann, P. Ramage, S. Rieffel, A. Strauss, J.R. Green, W. Jahnke, ChemMedChem. 1, 267 (2006) http://dx.doi.org/10.1002/cmdc.200500059[Crossref]
  • [13] J.E. Dunford, K. Thompson, F.P. Coxon, S.P. Luckman, F.M. Hahn, C.D. Poulter, F.H. Ebetino, M.J. Rogers, J. Pharmacol. Exp. Ther. 296, 235 (2001)
  • [14] N.B. Watts, S. Adami, C.H. Chesnut, J. Bone Miner Res. 16, S407 (2001)
  • [15] S. Boonen, M.L. Brandi, T. Harrington, I. Barton, L.G. Ste-Marie, Osteoporosis Int. 13, S15 (2002)
  • [16] M. McClung, New Engl. J. Med. 344, 1721 (2001) http://dx.doi.org/10.1056/NEJM200102013440503[Crossref]
  • [17] R.P. Heaney, T.M. Zizic, I. Fogelman, W.P. Olszynski, P. Geusens, C. Kasibhatla, N. Alsayed, G. Isaia, M.W. Davie, C.H. Chesnut, Osteoporosis Int. 13, 501 (2002) http://dx.doi.org/10.1007/s001980200061[Crossref]
  • [18] S. Wallach, S. Cohen, D.M. Reid, R.A. Hughes, D.J. Hosking, R.F. Laan, S.M. Doherty, M. Maricic, C. Rosen, J. Brown, I. Barton, A.A. Chines, Calcified Tissue Int. 67, 277 (2000) http://dx.doi.org/10.1007/s002230001146[Crossref]
  • [19] D.M. Reid, S. Adami, J.P. Devogelaer, A.A. Chines, Calcified Tissue Int. 69, 242 (2001) http://dx.doi.org/10.1007/s00223-001-1060-8[Crossref]
  • [20] D.Y. Mitchell, R.A. Eusebio, L.E. Dunlap, K.A. Pallone, J.D. Nesbitt, D.A. Russell, M.E. Clay, P.J. Bekker, Pharm. Res. 15, 228 (1998) http://dx.doi.org/10.1023/A:1011910517200[Crossref]
  • [21] D.Y. Mitchell, M.A. Heise, K.A. Pallone, M.E. Clay, J.D. Nesbitt, D.A. Russell, C.W. Melson, Br. J. Clin. Pharmacol. 48, 536 (1999) http://dx.doi.org/10.1046/j.1365-2125.1999.00035.x[Crossref]
  • [22] P.T. Vallano, S.B. Shugarts, W.F. Kline, E.J. Woolf, B.K. Matuszewski, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 794, 23 (2003) http://dx.doi.org/10.1016/S1570-0232(03)00394-5[Crossref]
  • [23] D. Kyriakides, I. Panderi, Anal. Chim. Acta 584, 153 (2007) http://dx.doi.org/10.1016/j.aca.2006.11.012[Crossref]
  • [24] A.M. Hounslow, J. Carran, R.J. Brown, D. Rejman, G.M. Blackburn, D.J. Watts, J. Med. Chem. 51, 4170 (2008) http://dx.doi.org/10.1021/jm7015792[Crossref]
  • [25] M. Meloun, S. Bordovská, T. Syrový, A. Vrána, Anal. Chim. Acta. 580, 107 (2006) http://dx.doi.org/10.1016/j.aca.2006.07.043[Crossref]
  • [26] M. Meloun, T. Syrový, S. Bordovská, A. Vrána, Anal. Bioanal. Chem. 387, 941 (2007) http://dx.doi.org/10.1007/s00216-006-0993-1[Crossref]
  • [27] M. Meloun, M. Javůrek, J. Havel, Talanta 33, 513 (1986) http://dx.doi.org/10.1016/0039-9140(86)80263-6[Crossref]
  • [28] D.J. Leggett, Computational methods for the determination of formation constants (Plenum Press, New York, 1985)
  • [29] H. Gampp, M. Maeder, C.J. Meyer, A.D. Züberbuhler, Talanta 32, 95 (1985) http://dx.doi.org/10.1016/0039-9140(85)80035-7[Crossref]
  • [30] H. Gampp, M. Maeder, C.J. Meyer, A.D. Züberbuhler, Talanta 32, 257 (1985) [Crossref]
  • [31] H. Gampp, M. Maeder, C.J. Meyer, A.D. Züberbuhler, Talanta 32, 1133 (1985) http://dx.doi.org/10.1016/0039-9140(85)80238-1[Crossref]
  • [32] M. Meloun, Z. Ferenčíková, A. Vrána, J. Chem. Thermodyn. 43, 930 (2011) http://dx.doi.org/10.1016/j.jct.2011.01.012[Crossref]
  • [33] M. Meloun, J. Militký, M. Forina, Chemometrics for analytical chemistry, PC-Aided Statistical Data Analysis (Ellis Horwood, Chichester, 1992) vol. 1
  • [34] M. Meloun, S. Bordovská, A. Vrána, Anal. Chim. Acta 584, 419 (2007) http://dx.doi.org/10.1016/j.aca.2006.11.049[Crossref]
  • [35] M. Meloun, J. Havel, E. Högfeldt, Computation of Solution Equilibria: A Guide to Methods in Potentiometry, Extraction, and Spectrophotometry (Prentice Hall, Chichester, London, 1988)
  • [36] SPECFIT/32 in Spectrum Software Associates, 197M Boston Post Road West, Marlborough, MA, 01752 U.S.A., 2004
  • [37] C. Rigano, M. Grasso, S. Sammartano, Ann. Chim. (Rome) 74, 537 (1984)
  • [38] C. De Stefano, P. Princi, C. Rigano, S. Sammartano, Ann. Chim. (Rome) 77, 643 (1987)
  • [39] P. Gans, A. Sabatini, A. Vacca, Talanta 43, 1739 (1996) http://dx.doi.org/10.1016/0039-9140(96)01958-3[Crossref]
  • [40] Origin 8.5 (OriginLab Corporation, Northampton, 2010)
  • [41] S-PLUS 4.5 (MathSoft Inc., Seattle, Washington, USA, 1998)
  • [42] ADSTAT 1.25, 3.0 (Windows 95) (TriloByte Statistical Software Ltd., Pardubice, 1990)
  • [43] Z. Gulyás, G. Pöcze, A. Petz, F. Darvas, Pallas cluster-a new solution to accelerate the high-throughut ADME-TOX prediction, ComGenex-CompuDrug, PKALC/PALLAS 2.1 CompuDrug Chemistry Ltd., http://www.compudrug.com.
  • [44] M. Meloun, J. Čapek, P. Mikšík, R.G. Brereton, Anal. Chim. Acta, 423, 51 (2000) http://dx.doi.org/10.1016/S0003-2670(00)01100-4[Crossref]
  • [45] M. Takami, K. Suda, T. Sahara, K. Itoh, K. Nagai, T. Sasaki, N. Udagawa, N. Takahashi, Bone 32, 341 (2003) http://dx.doi.org/10.1016/S8756-3282(03)00024-3[Crossref]
  • [46] G.H. Nancollas, R. Tang, R.J. Phipps, Z. Henneman, S. Gulde, W. Wu, A. Mangood, R.G. Russell, F.H. Ebetino, Bone 38, 617 (2006) http://dx.doi.org/10.1016/j.bone.2005.05.003[Crossref]
  • [47] M.I. Kabachnik, T.Y. Medved, N.M. Dyaglova, Y.M. Polikarpov, B.K. Shcherbakov, F.I. Belskii, Bull. Acad. Sci. USSR Div. Chem. Sci. 27, 374 (1978) http://dx.doi.org/10.1007/BF00923879[Crossref]
  • [48] G. Hägele, Z. Szakacs, J. Ollig, S. Hermens, C. Pfaff, Heteroat. Chem. 11, 562 (2000) http://dx.doi.org/10.1002/1098-1071(2000)11:7<562::AID-HC16>3.0.CO;2-V[Crossref]
  • [49] M. Dyba, M. Jezowska-Bojczuk, E. Kiss, T. Kiss, H. Kozlowski, Y. Leroux, D. ElManouni, J. Chem. Soc., Dalton Trans. 1119 (1996) [Crossref]
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11532-011-0150-3
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.